FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, particularly to a composition for potassium channel regulation in a myocardial cell. The pharmaceutical composition for potassium channel regulation in a myocardial cell containing Ginseng in the form of ethanol extract, Ophiopogonis in the form of concentrated water infusion, Corni in the form of ethanol extract, Radix Salviae Miltiorrhizae in the form of ethanol extract, fried seeds Ziziphi spinosae in the form of concentrated water infusion, Taxilli in the form of concentrated water infusion, Rubra in the form of concentrated water infusion, Steleophaga, taken in certain amounts. The use of the pharmaceutical composition for preparing a drug for potassium channel regulation in a myocardial cell in treating supraventricular arrhythmia, ventricular tachycardia, ventricular flutter, ventricular fibrillation, premature atrial contractions, atrial tachycardia, atrial flutter or atrial fibrillation. A method for preparing the pharmaceutical composition.
EFFECT: composition effectively regulates potassium channels in a myocardial cell.
10 cl, 8 dwg, 5 ex
